SCHEMBL27100620

SCHEMBL27100620

Cc1cc(Br)c2c(c1)c(C)c(C(=O)O)n2C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.53
MYC P01106 1/20 0.39
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
PRNP P04156 1/20 0.35
PPARG P37231 1/20 0.35
HTT P42858 1/20 0.35
NCOA2 Q15596 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
LDHA P00338 1/20 0.34
LDHB P07195 1/20 0.34
MCL1 Q07820 3/20 0.34
TPMT P51580 1/20 0.33
USP2 O75604 1/20 0.33
CTSG P08311 1/20 0.32
CMA1 P23946 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16571169 0.84 GPR35 (0.54) GPR35MEN1KMT2AL3MBTL1MCL1
SCHEMBL16571274 0.84 GPR35 (0.50) GPR35MEN1KMT2AL3MBTL1MCL1
SCHEMBL26581487 0.83 GPR35 (0.44) GPR35MEN1KMT2ALDHALDHB
SCHEMBL20605044 0.83 XDH (0.43) GPR35MEN1KMT2AL3MBTL1NPSR1
SCHEMBL16571637 0.81 GPR35 (0.47) GPR35MEN1KMT2AL3MBTL1USP2
SCHEMBL21115306 0.74 ALDH1A1 (0.31) MYCMEN1KMT2AALDH1A1KDM4E
SCHEMBL24756083 0.71 GPR35 (0.45) GPR35MEN1KMT2AL3MBTL1MCL1
SCHEMBL8692545 0.71 GPR35 (0.42) GPR35MCL1TPMTUSP2CTSG
SCHEMBL16571398 0.71 GPR35 (0.36) GPR35MEN1KMT2AL3MBTL1MCL1
SCHEMBL16570951 0.71 GPR35 (0.39) GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 GPR35 3148/4885MYC 25/4885MEN1 3549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.